Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue
−9.55%
EPS
−31.5%
Free cash flow
−31.6%
Total debt
−22.9%

Quarter to June 2026, against a year earlier

212.96 3.77 +1.80%
Market cap
$58.2B
P/E
64.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
7/9
Altman Z
1.85
Beneish M
−2.64
Dividend safety
67/100
Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21 Sep '22 Sep '23 Sep '24 Sep '25
P/E ratio
30.03 32.26 422.98 50.08 66.33 27.89 30.13 41.34 32.43 25.65
Piotroski F-Score
— 5 4 7 5 7 5 5 6 7
Altman Z-Score
2.44 2.24 1.68 1.87 1.76 2.01 2.01 2.27 1.99 1.85
P/S ratio
2.35 2.79 3.35 3.10 3.17 2.91 2.69 3.05 2.77 1.97
Altman Z″-Score (non-manufacturers)
2.95 4.61 1.64 1.89 2.09 2.21 2.22 2.49 2.24 2.29
P/FCF ratio
15.71 18.48 27.18 22.56 23.47 19.01 33.93 27.91 17.93 16.14
P/Operating CF
41.59 29.92 41.00 39.04 57.89 66.29 52.24 44.57 47.46 23.27
Beneish M-Score
(2.80) (2.72) (1.95) (2.67) (2.60) (2.73) (2.59) (2.43) (2.57) (2.64)
Dividend Safety Score
— — — — — — — — — 67
P/B ratio
3.84 2.60 2.55 2.54 2.14 2.35 2.01 2.29 2.16 1.70
EV/Sales
3.04 3.16 4.45 4.11 4.05 3.68 3.37 3.73 3.55 2.74
EV/EBITDA
14.92 14.62 20.42 17.69 21.53 15.72 14.08 16.44 15.28 11.89
EV/FCF
20.35 20.93 36.14 29.92 30.06 24.03 42.42 34.17 22.94 22.44
Current Ratio
1.45 5.58 1.03 1.18 1.54 1.33 1.04 1.31 1.17 1.11
Net Debt/EBITDA
3.40 1.71 5.06 4.35 4.72 3.28 2.82 3.01 3.34 3.33
Debt/Equity
1.38 1.44 0.90 0.86 0.72 0.72 0.55 0.57 0.69 0.69
ROE
13.19% 10.01% 0.94% 5.14% 3.42% 8.44% 6.90% 5.58% 6.60% 6.54%
ROA
3.75% 3.25% 0.35% 2.05% 1.45% 3.71% 3.16% 2.69% 3.10% 2.98%
ROIC
5.49% 5.46% 2.44% 2.85% 1.50% 3.67% 3.75% 3.38% 3.61% 3.82%
Return on Tangible Assets
16.63% 5.17% 2.85% 16.23% 8.47% 24.37% 26.63% 16.57% 20.46% 21.14%
Average Days of Receivables
47.31 52.64 52.96 49.50 54.45 44.84 42.38 47.74 54.86 50.04
Earnings Yield
3.33% 3.10% 0.24% 2.00% 1.51% 3.59% 3.32% 2.42% 3.08% 3.90%
Free Cash Flow Yield
6.36% 5.41% 3.68% 4.43% 4.26% 5.26% 2.95% 3.58% 5.58% 6.20%
Free Cash Flow per Share
8.77 8.33 7.63 8.79 7.77 10.14 5.26 7.39 10.76 9.28
Book value per Share
35.89 59.14 81.26 78.09 85.19 81.85 88.71 90.11 89.35 88.27
Free Cash Flow
1,866.00 1,823.00 1,970.00 2,373.00 2,168.00 2,932.00 1,498.00 2,116.00 3,119.00 2,670.00
EV/EBIT
26.55 25.07 47.18 40.34 71.46 31.30 27.83 34.25 29.84 23.24
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026